Moreover, we also found the reduced expression of CXCR4 protein by the treatment with vesnarinone, as compared to the effects of 5-FU and CDDP both in ACC-M cells and in Hela cells (Additional File 1). This evidence concerns the gene CXCR4 and adrenal cortex carcinoma.